Speciality Medicines IPO Opens For Subscription Today

Speciality Medicines initial public offering (IPO) opens for subscription on Friday, 20 March. The company plans to raise about ₹29 crore through a fully fresh issue. The offer will close on 24 March. Shares are scheduled to list on the BSE SME platform on 30 March. The price band has been fixed at ₹117–124 per share.

Other Key IPO Details

Here are the other key details of the Speciality Medicines IPO:

Business Model And Operations

Incorporated in 2021, Speciality Medicines operates in the speciality pharma segment. The company focuses on the marketing and distribution of high-value formulations used in chronic and complex treatments. Its portfolio includes:

• Injectables
• Inhalers
• Ophthalmic products
• Oral formulations

The company follows a dual model. It undertakes contract manufacturing for overseas markets while also distributing sourced speciality pharma products. The company has a presence in more than 35 countries and operates across over 20 states in India.

Also Read - Central Bank Faces ₹1.44 Lakh Crore Bad Loans, Initiates 4,903 Recovery Cases

Use Of Proceeds

The IPO proceeds will be deployed across multiple areas:

• Setting up a new research and development (R&D) centre in Gujarat
• Funding international product registrations
• Supporting marketing activities
• Meeting working capital needs

The research and development investment comes as the company looks to scale its product pipeline and expand overseas registrations.

Sources:

The Economic Times

India IPO

Chittorgarh